Secondary malignant neoplasm of female breast
Item
diagnosis of metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Exclusion Criteria | Secondary malignant neoplasm of skin Hand | Secondary malignant neoplasm of skin Foot
Item
no cutaneous metastases on hands or feet
boolean
C0680251 (UMLS CUI [1])
C0153687 (UMLS CUI [2,1])
C0018563 (UMLS CUI [2,2])
C0153687 (UMLS CUI [3,1])
C0016504 (UMLS CUI [3,2])
Indication Pegylated liposomal doxorubicin hydrochloride
Item
pegylated liposomal doxorubicin hydrochloride monotherapy is indicated according to the local investigator
boolean
C3146298 (UMLS CUI [1,1])
C1522690 (UMLS CUI [1,2])
Planned Dose U/week
Item
planned dose at least 10 mg/m^2 per week
boolean
C2826283 (UMLS CUI [1,1])
C0560588 (UMLS CUI [1,2])
Exclusion | Sign Palmar-plantar erythrodysesthesia
Item
no sign of palmar-plantar erythrodysesthesia (ppe) at study entry
boolean
C2828389 (UMLS CUI [1])
C0311392 (UMLS CUI [2,1])
C0549410 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
WHO performance status scale
Item
who performance status 0-2
boolean
C1298650 (UMLS CUI [1])
Ability Apply Topical Cream
Item
able to apply topical medication (cream) or provide for another person to apply cream
boolean
C0085732 (UMLS CUI [1,1])
C4048755 (UMLS CUI [1,2])
C0991551 (UMLS CUI [1,3])
Exclusion Criteria | Pregnancy | Breast Feeding
Item
not pregnant or breastfeeding
boolean
C0680251 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception during trial participation and for 1 month after completion
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Compliance behavior Evaluation | Compliance behavior Follow-up | Patients Geographic Proximal
Item
compliant and geographically proximal in order to allow proper evaluation and follow-up
boolean
C1321605 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
C0030705 (UMLS CUI [3,1])
C1517526 (UMLS CUI [3,2])
C0205107 (UMLS CUI [3,3])
Exclusion Criteria | Dermatologic disorders Affecting Hand | Dermatologic disorders Affecting Foot | Dermatologic disorders Complicating Evaluation | Psoriasis
Item
no dermatologic conditions (e.g., psoriasis) that, in the opinion of the physician, may affect the hands or feet or may complicate evaluation during study treatment
boolean
C0680251 (UMLS CUI [1])
C0037274 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0018563 (UMLS CUI [2,3])
C0037274 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0016504 (UMLS CUI [3,3])
C0037274 (UMLS CUI [4,1])
C1522701 (UMLS CUI [4,2])
C1261322 (UMLS CUI [4,3])
C0033860 (UMLS CUI [5])
Exclusion | Hypersensitivity Cream F511
Item
no known allergy or hypersensitivity to f511 cream
boolean
C2828389 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C2981805 (UMLS CUI [2,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.16
Item
see disease characteristics
boolean
Exclusion Criteria | Investigational New Drugs | Cancer treatment
Item
more than 30 days since prior and no concurrent treatment with other experimental drugs or anticancer therapy
boolean
C0680251 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0920425 (UMLS CUI [3])
Exclusion | Study Subject Participation Status | Therapies, Investigational
Item
more than 30 days since prior and no concurrent treatment on another clinical trial
boolean
C2828389 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
Exclusion Criteria | Ointments Hand Use of Local | Ointments Foot Use of Local | Cream Hand Use of Local | Cream Foot Use of Local | Exception Cream Specified
Item
no concurrent local use of other ointments or creams for hands or feet other than excipial repair®
boolean
C0680251 (UMLS CUI [1])
C0028912 (UMLS CUI [2,1])
C0018563 (UMLS CUI [2,2])
C1524063 (UMLS CUI [2,3])
C0205276 (UMLS CUI [2,4])
C0028912 (UMLS CUI [3,1])
C0016504 (UMLS CUI [3,2])
C1524063 (UMLS CUI [3,3])
C0205276 (UMLS CUI [3,4])
C3494477 (UMLS CUI [4,1])
C0018563 (UMLS CUI [4,2])
C1524063 (UMLS CUI [4,3])
C0205276 (UMLS CUI [4,4])
C3494477 (UMLS CUI [5,1])
C0016504 (UMLS CUI [5,2])
C1524063 (UMLS CUI [5,3])
C0205276 (UMLS CUI [5,4])
C1705847 (UMLS CUI [6,1])
C3494477 (UMLS CUI [6,2])
C0205369 (UMLS CUI [6,3])